Kismet
AdobeStock_162640208.jpeg

Shared Journey Fertility Program

 

We have extensive knowledge and experience in working with women who have experienced fertility challenges due to endometriosis, PCOS, diminished ovarian reserve, blocked fallopian tubes, recurring miscarriage, failed medical attempts such as IVF and secondary fertility issues.


The Shared Journey Fertility Program

DSC_0144__Version_2-1024x731.jpg

Our fertility program is 6 weeks in length and can be used as a stand alone regime or in preparation for a more medically assisted cycle such as IUI or IVF. It is highly recommend that you prepare your body properly prior to starting any medically assisted fertility cycle to help insure a successful first cycle. The Shared Journey can be completed in time for your stim start. 

 You will be guided to monitor your own ovulatory cycle along with our help for up to one year after finishing your therapy with us. 

The program is custom tailored to each individual woman's situation and will be discussed in further detail at a consultation. 

Mercier Therapy is a deep pelvic organ visceral manipulation modality. When increasing blood flow, you're optimizing the true function of the area and helping to return blood flow which is therapeutic. When choosing to start the SJFP you'll receive 6 full hours of MT broken down into 1 hour intervals per week for 6 weeks. 

The Journey Includes:

  • First month of supplements

    • includes bio-identical progesterone, pre-natal vitamins and other fertility boosting supplements
      tailored to your specific needs

  • six 1hr MT treatments

    • intense six week Mercier therapy plan

  • Shared Journey

    • Ovulation calendar and journal

  • 1 year of consultatioN

    • follow up consultations for a year beginning after the treatment is complete

The first step is to schedule an appointment for the Shared Journey Consult, where we will review your medical history in detail, a breakdown of each supplement that is part of the initial package and discuss the program in great detail.


Articles have been written about soft tissue abdominal and pelvic work alleviating fertility challenges, but no clinical research has been performed. The purpose of this study is to confirm that the use of Merciér Therapy—site-specific, manual soft tissue therapy—is valid as a standalone treatment and with assisted reproductive technologies to help women become pregnant.

From 2013 to 2018, 171 women ages 27–42 were interviewed, underwent six hours of Merciér Therapy, and were supplied with organic food-based prenatal vitamins containing a methylated folate. Merciér Therapy’s research setting is a relaxing holistic clinical environment in Illinois. The women selected for the study all complained of primary and secondary fertility challenges regardless of age, current or past pathological condition, prior surgical intervention, and treatment history (including no prior treatment).

In all, 150 women (87.7%) who underwent Merciér Therapy prior to IVF stimulation achieved pregnancy: 142 women (83%) through IVF, and 8 women (4.7%) through natural means. With the first IVF cycle, 87 women (50.9%) achieved pregnancy. With the second IVF cycle, 44 women (25.7%) achieved pregnancy. With the third IVF cycle, 11 (6.4%) achieved pregnancy. In addition, 21 (12.3%) did not become pregnant.

Merciér Therapy has proven beneficial in helping couples to achieve pregnancy in a diverse group of women with various prior assisted reproductive technology backgrounds, ages, races, current pathologies, and medical histories.